Another solid announcement keep them coming SI - in years to come we'll look back at today's prices and will be in awe !!!!
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis
MSB
mesoblast limited
Add to My Watchlist
5.26%
!
$2.40

Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.40 |
Change
0.120(5.26%) |
Mkt cap ! $3.084B |
Open | High | Low | Value | Volume |
$2.31 | $2.43 | $2.30 | $12.53M | 5.288M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 32185 | $2.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.41 | 30041 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
50 | 55806 | 2.400 |
26 | 136976 | 2.390 |
18 | 145959 | 2.380 |
12 | 142633 | 2.370 |
11 | 78817 | 2.360 |
Price($) | Vol. | No. |
---|---|---|
2.410 | 36776 | 29 |
2.420 | 76697 | 33 |
2.430 | 137789 | 18 |
2.440 | 78957 | 12 |
2.450 | 194233 | 22 |
Last trade - 15.05pm 23/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |